The healthcare sector climbed 1.11% at midday Tuesday.
Stocks rallied after some volatility on Wall Street, with investors cautiously optimistic after a temporary pause on tariffs on some electronic devices. The S&P 500 closed up 2.2%.
Botanix Pharmaceuticals (ASX:BOT) received firm commitments to raise AU$40 million via a non-underwritten institutional placement, its shares rose 9% in midday trade.
On the flip side, the information technology stocks fell, shedding 0.45%.
EROAD (ASX:ERD, NZE:ERD) does not expect any material impact of the US' 10% blanket tariffs on its revenue or earnings, generating 44% of its revenue from the US market, with roughly 88% being from services not subject to the US import tariffs. It produces most of its hardware products through manufacturers in Indonesia, the Philippines, and Vietnam.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。